In this study, we demonstrate that niclosamide can increase sorafenib sensitivity in sorafenib-resistant HCC cells/organoids through the regulation of insulin-like growth factor 1 receptor (IGF-1R)/p-IGF-1R/stemness and metabolic changes. Here, IGF1R is linked to hepatocellular carcinoma.